Progyny up 6% on insider buys
작성Ainvest
2024년 12월 27일 금요일 오전 8:44 ET1분 읽기
PGNY--
One of the most significant purchases was made by Ali Motamed, the Chief Investment Officer of Invenomic Capital Management. Motamed acquired 1,760,706 shares of PGNY, worth approximately $29.5 million [2]. This transaction represented a sizable 1.62% increase in Motamed's total holdings of the company [2].
Another notable insider purchase was made by Philip Timon, the Founder and Chief Investment Officer of Owls Nest Partners. Timon sold 1,523,147 shares of PGNY but simultaneously purchased 1,523,147 new shares [2]. Although this transaction resulted in no net change to Timon's overall holdings, it demonstrated his confidence in the company's future prospects.
The hedge fund with the largest stake in PGNY is Farallon Capital, managed by Thomas Steyer. Steyer reduced his holdings by selling 931,307 shares of the company, worth around $15.6 million [2]. Despite this sale, Steyer still holds a significant 0.07% stake in PGNY [2].
Steve Cohen, the Founder and Chief Executive Officer of Point72 Asset Management, also made a notable purchase of 789,418 shares of PGNY, worth approximately $13.2 million [2]. This transaction represented a substantial 228% increase in Cohen's total holdings of the company [2].
Israel Englander, the Founder and Chief Investment Officer of Millennium Management, acquired 563,535 shares of PGNY, worth around $9.4 million [2]. This purchase represented a 6% increase in Englander's overall holdings of the company [2].
The insider buying activity at PGNY is a positive sign for the company, as it demonstrates confidence from key executives and prominent investors. With a strong focus on fertility benefits, PGNY is well-positioned to capitalize on the growing demand for healthcare services in this area [1].
References:
[1] OpenInsider. Progyny Inc. Retrieved November 15, 2024, from http://openinsider.com/PGNY
[2] Insidermonkey. Progyny Inc. Hedge Fund Trading. Retrieved November 15, 2024, from https://www.insidermonkey.com/insider-trading/company/progyny+inc/1551306/
Progyny up 6% on insider buys
Progyny Inc. (PGNY), a healthcare services company specializing in fertility benefits, experienced a notable surge of 6% in its stock price on November 14, 2024 [1]. This uptick can be attributed to a series of insider purchases made by key executives and prominent hedge funds [2].One of the most significant purchases was made by Ali Motamed, the Chief Investment Officer of Invenomic Capital Management. Motamed acquired 1,760,706 shares of PGNY, worth approximately $29.5 million [2]. This transaction represented a sizable 1.62% increase in Motamed's total holdings of the company [2].
Another notable insider purchase was made by Philip Timon, the Founder and Chief Investment Officer of Owls Nest Partners. Timon sold 1,523,147 shares of PGNY but simultaneously purchased 1,523,147 new shares [2]. Although this transaction resulted in no net change to Timon's overall holdings, it demonstrated his confidence in the company's future prospects.
The hedge fund with the largest stake in PGNY is Farallon Capital, managed by Thomas Steyer. Steyer reduced his holdings by selling 931,307 shares of the company, worth around $15.6 million [2]. Despite this sale, Steyer still holds a significant 0.07% stake in PGNY [2].
Steve Cohen, the Founder and Chief Executive Officer of Point72 Asset Management, also made a notable purchase of 789,418 shares of PGNY, worth approximately $13.2 million [2]. This transaction represented a substantial 228% increase in Cohen's total holdings of the company [2].
Israel Englander, the Founder and Chief Investment Officer of Millennium Management, acquired 563,535 shares of PGNY, worth around $9.4 million [2]. This purchase represented a 6% increase in Englander's overall holdings of the company [2].
The insider buying activity at PGNY is a positive sign for the company, as it demonstrates confidence from key executives and prominent investors. With a strong focus on fertility benefits, PGNY is well-positioned to capitalize on the growing demand for healthcare services in this area [1].
References:
[1] OpenInsider. Progyny Inc. Retrieved November 15, 2024, from http://openinsider.com/PGNY
[2] Insidermonkey. Progyny Inc. Hedge Fund Trading. Retrieved November 15, 2024, from https://www.insidermonkey.com/insider-trading/company/progyny+inc/1551306/

편집 공시 및 AI 투명성: Ainvest News는 대규모 언어 모델(LLM) 기술을 활용해 실시간 시장 데이터를 통합·분석합니다. 최고 수준의 정직성을 보장하기 위해 모든 기사는 엄격한 "Human-in-the-loop(인간 검증)" 절차를 거칩니다.
AI가 데이터 처리 및 초안 작성을 보조하지만, Ainvest 전문 편집 구성원이 모든 콘텐츠를 독립적으로 검토·팩트 체크·승인하여 정확성과 Ainvest Fintech Inc.의 편집 기준 준수를 확인합니다. 이러한 인간의 감독은 AI 환각을 완화하고 금융 맥락을 확보하기 위한 것입니다.
투자 유의: 본 콘텐츠는 정보 제공 목적으로만 제공되며 전문적인 투자·법률·재무 자문을 구성하지 않습니다. 시장에는 고유한 위험이 있습니다. 의사 결정 전에 사용자는 자체 연구를 수행하거나 자격을 갖춘 재무 고문과 상담할 것을 권장합니다. Ainvest Fintech Inc.는 본 정보를 바탕으로 한 조치에 대한 모든 책임을 부인합니다. 오류를 발견하셨나요?문제 신고



댓글
아직 댓글이 없습니다